Ophthalmic Drugs Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

The Ophthalmic Drugs Market size is expected to grow at an annual average of 5% during 2021-2027. Ophthalmic drugs are formulations designed to treat eye conditions such as cataracts, glaucoma, color blindness, diabetic macular edema, cytomegalovirus (CMV) retinitis, and age-related macular degeneration (AMD).

The following segmentation are covered in this report:

By Type

• Prescription Drugs
• Over-the-counter Drugs

By Dosage Form

• Liquid Ophthalmic Drug Forms
• Solid Ophthalmic Drug Forms
• Semisolid Ophthalmic Drug Forms
• Multicompartment Drug Delivery Systems
• Other Ophthalmic Drug Forms

By Distribution Channel

• Hospital Pharmacies
• Drug Stores
• Online Pharmacies
• Others

Company Profile

• AbbVie Inc. (Allergan plc)
• Alcon Inc.
• Bausch & Lomb Incorporated
• F. Hoffmann-La Roche Ltd (Genentech, Inc.)
• Novartis AG
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co., Ltd.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd. (Actavis Generics)

Scope of the report

The research study analyses the Ophthalmic Drugs Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Ophthalmic Drugs Market Report

• What was the Ophthalmic Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Ophthalmic Drugs Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.